ResearcherYeditepe UniversityActive in the last 2 years

Hande Si̇pahi̇

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6482-3143; OpenAlex author ID A5015694731. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

In Vitro Evidence for the Dual Antioxidant and Anti-Inflammatory Roles of Hypericum triquetrifolium in Cancer Therapy: Selective Cytotoxicity Against Pancreati… Last author DOI 10.3390/molecules31101628 ↗
Discovery of Novel Thiophene/Hydrazones: In Vitro and In Silico Studies against Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics15051441 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dilek Telci · 1 shared paper, 2026 · strength 0.32
- Paper In Vitro Evidence for the Dual Antioxidant and Anti-Inflammatory Roles of Hypericum triquetrifolium in Cancer Therapy: … DOI 10.3390/molecules31101628 ↗
Ece Sabuncu · 1 shared paper, 2026 · strength 0.32
- Paper In Vitro Evidence for the Dual Antioxidant and Anti-Inflammatory Roles of Hypericum triquetrifolium in Cancer Therapy: … DOI 10.3390/molecules31101628 ↗
Göknil Pelin Coşkun · 1 shared paper, 2023 · strength 0.19
- Paper Discovery of Novel Thiophene/Hydrazones: In Vitro and In Silico Studies against Pancreatic Cancer. DOI 10.3390/pharmaceutics15051441 ↗
Şeref Demirayak · 1 shared paper, 2023 · strength 0.19
- Paper Discovery of Novel Thiophene/Hydrazones: In Vitro and In Silico Studies against Pancreatic Cancer. DOI 10.3390/pharmaceutics15051441 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.